eCF309 |
eCF309 : ATP competitive inhibitor of MTOR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MTOR |
|
|
ATP competitive
20-50 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - DDR1/2 2,110 nM, DNA-PK 320 nM, PI3Kα 981 nM, PI3Kβ >10,000 nM, PI3Kγ 1,340 nM, PI3Kδ 1,840 nM
Selectivity Assessment Description:
Kinome profiling of eCF309 against 375 wild type and mutant kinases was performed at 10 μM. mTOR was ...
Potency Cellular
In Vitro
MTOR
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? No
Chemical Information
| Molecular Formula | C18H21N7O3 |
| SMILEs | CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC |
| InChI | InChI=1S/C18H21N7O3/c1-3-26-13(27-4-2)8-25-17-14(16(19)21-9-22-17)15(24-25)10-5-6-12-11(7-10)23-18(20)28-12/h5-7,9,13H,3-4,8H2,1-2H3,(H2,20,23)(H2,19,21,22) |
| Molecular weight | 383.17 Da |
| AlogP | 2.1980000000000004 |
| HBond acceptors | 10 |
| HBond donors | 4 |
| Atoms | 49 |
References
Publications
Cross References
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.